Intermediate III of anti-hepatitis C virus drug Boceprevir, and preparation method and application thereof

The technology of a compound and a compound of the general formula is applied in the field of preparation of the anti-hepatitis C drug Boceprevir, and can solve the problems of side reactions, reaction detection and intermediate control troubles, etc.

Inactive Publication Date: 2014-07-23
SHANGHAI INST OF PHARMA IND +1
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the existing synthetic methods all have the same problem: since there is no obvious chromophoric group in the structure of each intermediate, the reaction detection and intermediate control are

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Intermediate III of anti-hepatitis C virus drug Boceprevir, and preparation method and application thereof
  • Intermediate III of anti-hepatitis C virus drug Boceprevir, and preparation method and application thereof
  • Intermediate III of anti-hepatitis C virus drug Boceprevir, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-9

[0056] Embodiment 1-9: R is the preparation of formula 1 compound of hydrogen

Embodiment 1

[0057] Embodiment 1: the preparation of compound B

[0058]

[0059] Compound A (5g, 20.6mmol) was dissolved in 40ml DMF and added to a three-neck flask, cooled to -5°C; NaH (60%, 1.1g, 26.8mmol) was added in batches and stirred for 1h, then added dropwise at -5°C 40ml of BnBr (4.2g, 24.7mmo) DMF solution, after the dropwise addition, stir at this temperature for 2h, add ice water to quench the reaction, extract with ethyl acetate, a small amount of multiple times, combine the organic phases, wash with saturated brine Drying over anhydrous sodium sulfate and distilling off the solvent gave a yellow oil, and column chromatography gave 6.2 g of compound B as a white solid, yield 90.4%, m / z (MH+) 334.16, 1H NMR (400 MHz, CDCl ) δ 1.31 ( t,3H),1.41-1.57(m,4H),1.64-1.74(m,2H),1.77(s,3H),1.96-2.06(m,2H),2.25-2.29(m,1H),3.95( d, 1H), 4.19-4.25(m, 3H), 4.28(d, 1H), 4.81(d, 1H), 5.63(d, 1H), 7.30-7.35(m, 5H).

Embodiment 2

[0060] Embodiment 2: the preparation of compound C

[0061]

[0062] Compound B (5g, 15mmol), DMAP (0.37g, 3mmol) were dissolved in 60ml of THF, added (Boc) 2After O (6.88ml, 30mmol), the temperature was raised to reflux, and after reflux for about 8 hours, it was lowered to room temperature, and 60ml of methanol and hydrazine hydrate (3g, 60mmol) were added to stir for 4 hours, and then 200ml of dichloromethane was added to dilute, and the reaction solution was sequentially diluted with 1N HCl and copper sulfate solution. , washed with saturated sodium bicarbonate solution and saturated brine, dried over anhydrous sodium sulfate, evaporated to remove the solvent to obtain a yellow oil, column chromatography obtained 4.4g of compound C as a white solid, yield 75.0%, m / z (MNa+) 414.06,1H NMR(400MHz,CDCl3)δ1.32(t,3H),1.44(s,9H),1.48-1.68(m,4H),1.78-1.87(m,2H),2.02-2.11(m,2H ),2.33-2.37(m,1H),3.98(m,1H),4.20-4.32(m,3H),4.43(d,1H),4.65(d,1H),4.81(d,1H),7.30- 7.37 (m, 5H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention belongs to the technical field of preparation methods of anti-hepatitis C virus drugs. The structural formula of a compound F-2 disclosed in the invention is as follows. The compound is easy to prepare, the preparation method is easy to operate, and the yield of the compound is high. The compound can be used for synthesis of an anti-hepatitis C virus drug Boceprevir, and a new concept and a new method for synthesis of the anti-hepatitis C virus drug Boceprevir can be provided. Compared with the existing synthesis method, the compound prepared by the preparation method can be more conveniently detected due to ultraviolet chromophoric groups in the molecule of the compound, introduction of a benzyl group to a hydroxyl group avoids side reactions in a condensation step which are caused by hydroxyl nucleophilicity, and thus the preparation method has certain advantages over the existing synthesis method.

Description

technical field [0001] The invention relates to the technical field of preparation methods for anti-hepatitis C drug Boceprevir. Background technique [0002] Globally, the infection rate of hepatitis C virus (HCV) is about 3%, and the total number of infected people is about 200 million. Because of the high infection rate of HCV and the serious potential complications such as liver cirrhosis and liver cancer, HCV is a serious threat to human life and health. According to the Simmonds naming system, HCV can be divided into six main genotypes, namely I-VI, and each type can be divided into several subtypes (such as Ia, Ib, IIa, IIb, IIIa, IIIb, etc.). There are about 40 million HCV-infected people in my country, 69% of which are type I infections (mainly type Ib). The current treatment of chronic hepatitis C is mainly the combination of pegylated interferon (PEG-IFNα) and ribavirin (RBV), which fails to produce sustained virological response in about 50% of HCV type I patie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D209/52
CPCY02P20/55C07D209/52C07K5/0202
Inventor 姚旻袁哲东杨玉雷张浩宇
Owner SHANGHAI INST OF PHARMA IND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap